Effects of hormone replacement therapy on immunological factors in the postmenopausal period

References

• Walf AA, Frye CA. A review and update of mechanisms of estrogen in the hippocampus and amygdala for anxiety and depression behavior. Neuropsychopharmacology 2006;31:1097–111
   PubMed Web of Science ®Google Scholar
• Brooks E, Morgan A, Pierzga J, et al. Chronic hormone replacement therapy alters thermoregulatory and vasomotor function in postmenopausal women. J Appl Physiol 1997;83:477–84
   PubMed Web of Science ®Google Scholar
• Zhu BT, Conney AH. Functional role of estrogen metabolism in target cells: review and perspectives. Carcinogenesis 1998;19:1–27
   PubMed Web of Science ®Google Scholar
• Burleson MH, Malarkey WB, Cacioppo JT, et al. Postmenopausal hormone replacement: effects on autonomic, neuroendocrine, and immune reactivity to brief psychological stressors. Psychosom Med 1998;60:17–25
   PubMed Web of Science ®Google Scholar
• Yazdkhasti M, Simbar M, Abdi F. Empowerment and coping strategies in menopause women: a review. Iran Red Crescent Med J 2015;17:e18944
   PubMed Web of Science ®Google Scholar
• Figueroa-Vega N, Moreno-Frías C, Malacara JM. Alterations in adhesion molecules, pro-inflammatory cytokines and cell-derived microparticles contribute to intima-media thickness and symptoms in postmenopausal women. PLoS One 2015;10:e0120990
   PubMed Web of Science ®Google Scholar
• Lynch EA, Dinarello CA, Cannon JG. Gender differences in IL-1 alpha, IL-1 beta, and IL-1 receptor antagonist secretion from mononuclear cells and urinary excretion. J Immunol 1994;153:300–6
   PubMed Web of Science ®Google Scholar
• Vihtamaki T, Simoni M, Tuimala R, Nieschlag E, Vihko KK. Self-adjusted postmenopausal hormone replacement therapy: effects on the biological and immunological profile of FSH and correlation to climacteric symptoms. Eur J Endocrinol 2002;146:333–8
   PubMed Web of Science ®Google Scholar
• Gameiro C, Romao F. Changes in the immune system during menopause and aging. Front Biosci 2009;2:1299–303
   Google Scholar
• Gameiro CM, Romão F, Castelo-Branco C. Menopause and aging: changes in the immune system – a review. Maturitas 2010;67:316–20
   PubMed Web of Science ®Google Scholar
• Cutolo M, Sulli A, Capellino S, et al. Sex hormones influence on the immune system: basic and clinical aspects in autoimmunity. Lupus 2004;13:635–8
   PubMed Web of Science ®Google Scholar
• Vural P, Akgul C, Canbaz M. Effects of hormone replacement therapy on plasma pro-inflammatory and anti-inflammatory cytokines and some bone turnover markers in postmenopausal women. Pharmacol Res 2006;54:298–302
   PubMed Web of Science ®Google Scholar
• Keller ET, Zhang J, Yao Z, Qi Y. The impact of chronic estrogen deprivation on immunologic parameters in the ovariectomized rhesus monkey (Macaca mulatta) model of menopause. J Reprod Immunol 2001;50:41–55
   PubMed Web of Science ®Google Scholar
• Bouman A, Heineman MJ, Faas MM. Sex hormones and the immune response in humans. Hum Reprod Update 2005;11:411–23
   PubMed Web of Science ®Google Scholar
• McMurray RW, Suwannaroj S, Ndebele K, Jenkins JK. Differential effects of sex steroids on T and B cells: modulation of cell cycle phase distribution, apoptosis and bcl-2 protein levels. Pathobiology 2001;69:44–58
   PubMed Web of Science ®Google Scholar
• Cutolo M, Villaggio B, Craviotto C, Pizzorni C, Seriolo B, Sulli A. Sex hormones and rheumatoid arthritis. Autoimmun Rev 2002;1:284–9
   PubMedGoogle Scholar
• Pacifici R. Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis. J Bone Miner Res 1996;11:1043–51
   PubMed Web of Science ®Google Scholar
• Fahlman MM, Boardley D, Flynn MG, Bouillon LE, Lambert CP, Braun WA. Effects of hormone replacement therapy on selected indices of immune function in postmenopausal women. Gynecol Obstet Invest 2000;50:189–93
   PubMed Web of Science ®Google Scholar
• Malarkey WB, Burleson M, Cacioppo JT, Poehlmann K, Glaser R, Kiecolt-Glaser JK. Differential effects of estrogen and medroxyprogesterone on basal and stress-induced growth hormone release, IGF-1 levels, and cellular immunity in postmenopausal women. Endocrine 1997;7:227–33
   PubMed Web of Science ®Google Scholar
• Zeng X, Zhang Y, Kwong JS, et al. The methodological quality assessment tools for preclinical and clinical studies, systematic review and meta‐analysis, and clinical practice guideline: a systematic review. J Evid Based Med 2015;8:2–10
   PubMedGoogle Scholar
• Straub R, Hense H, Andus T, Scholmerich J, Riegger G, Schunkert H. Hormone replacement therapy and interrelation between serum interleukin-6 and body mass index in postmenopausal women: a population-based study. J Clin Endocrinol Metab 2000;85:1340–4
   PubMed Web of Science ®Google Scholar
• Rahnama M, Jamrogiewicz I, Jamrogiewicz R. Analysis of the influence of hormone replacement therapy on TNF-alpha serum levels in menopausal women. Postepy higieny i medycyny doswiadczalnej 2012;66:1006–11
   Google Scholar
• Stopińska-Głuszak U, Waligóra J, Grzela T, et al. Effect of estrogen/progesterone hormone replacement therapy on natural killer cell cytotoxicity and immunoregulatory cytokine release by peripheral blood mononuclear cells of postmenopausal women. J Reprod Immunol 2006;69:65–75
   PubMed Web of Science ®Google Scholar
• Xia X, Zhang S, Yu Y, et al. Effects of estrogen replacement therapy on estrogen receptor expression and immunoregulatory cytokine secretion in surgically induced menopausal women. J Reprod Immunol 2009;81:89–96
   PubMed Web of Science ®Google Scholar
• Porter V, Greendale G, Schocken M, Zhu X, Effros R. Immune effects of hormone replacement therapy in post-menopausal women. Exp Gerontol 2001;36:311–26
   PubMed Web of Science ®Google Scholar
• Kumru S, Godekmerdan A, Yılmaz B. Immune effects of surgical menopause and estrogen replacement therapy in peri-menopausal women. J Reprod Immunol 2004;63:31–8
   PubMed Web of Science ®Google Scholar
• Yilmazer M, Fenkci V, Fenkci S, Aktepe O, Sonmezer M, Kurtay G. Association of serum complement (C3, C4) and immunoglobulin (IgG, IgM) levels with hormone replacement therapy in healthy post‐menopausal women. Hum Reprod 2003;18:1531–5
   PubMed Web of Science ®Google Scholar
• Saucedo R, Rico G, Basurto L, Ochoa R, Zárate A. Transdermal estradiol in menopausal women depresses interleukin-6 without affecting other markers of immune response. Gynecol Obstet Invest 2002;53:114–17
   PubMed Web of Science ®Google Scholar
• Abrahamsen B, Bonnevie‐Nielsen V, Ebbesen EN, Gram J, Beck-Nielsen H. Cytokines and bone loss in a 5‐year longitudinal study – hormone replacement therapy suppresses serum soluble interleukin‐6 receptor and increases interleukin‐1‐receptor antagonist: The Danish Osteoporosis Prevention Study. J Bone Miner Res 2000;15:1545–54
   PubMed Web of Science ®Google Scholar
• Scheidt-Nave C, Bismar H, Leidig-Bruckner G, et al. Serum interleukin 6 is a major predictor of bone loss in women specific to the first decade past menopause. J Clin Endocrinol Metab 2001;86:2032–42
   PubMed Web of Science ®Google Scholar
• Rachon D, Mysliwska J, Suchecka-Rachon K, Wieckiewicz J, Mysliwski A. Effects of oestrogen deprivation on interleukin-6 production by peripheral blood mononuclear cells of postmenopausal women. J Endocrinol 2002;172:387–95
   PubMed Web of Science ®Google Scholar
• d’Elia HF, Larsen A, Waltbrand E, et al. Radiographic joint destruction in postmenopausal rheumatoid arthritis is strongly associated with generalised osteoporosis. Ann J Rheumat Dis 2003;62:617–23
   PubMed Web of Science ®Google Scholar
• Yang J-H, Chen C-D, Wu M-Y, Chao K-H, Yang Y-S, Ho H-N. Hormone replacement therapy reverses the decrease in natural killer cytotoxicity but does not reverse the decreases in the T-cell subpopulation or interferon-gamma production in postmenopausal women. Fertil Steril 2000;74:261–7
   PubMed Web of Science ®Google Scholar
• Ferguson FG, Wikby A, Maxson P, Olsson J, Johansson B. Immune parameters in a longitudinal study of a very old population of Swedish people: a comparison between survivors and nonsurvivors. J Gerontol Series A: Biol Sci Med Sci 1995;50:B378–82
   PubMed Web of Science ®Google Scholar
• Mosmann T, Coffman R. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Ann Rev Immunol 1989;7:145–73
   PubMed Web of Science ®Google Scholar
• Hrekova S, Vodianyk M, Chernyshov V. [Effect of progesterone and 17beta-estradiol on proinflammatory cytokine costimulatory proliferative activity]. Fiziolohichnyi zhurnal 2001;48:63–9
   Google Scholar
• Piercy KT, Donnell RL, Kirkpatrick SS, et al. Effects of estrogen, progesterone, and combination exposure on interleukin-1β-induced expression of VCAM-1, ICAM-1, PECAM, and E-selectin by human female iliac artery endothelial cells. J Surg Res 2002;105:215–19
   PubMed Web of Science ®Google Scholar
• Kamada M, Irahara M, Maegawa M, et al. Postmenopausal changes in serum cytokine levels and hormone replacement therapy. Am J Obstet Gynecol 2001;184:309–14
   PubMed Web of Science ®Google Scholar
• Yasui T, Maegawa M, Tomita J, et al. Changes in serum cytokine concentrations during the menopausal transition. Maturitas 2007;56:396–403
   PubMed Web of Science ®Google Scholar
• Polan ML, Loukides J, Nelson P, et al. Progesterone and estradiol modulate interleukin-1 β messenger ribonucleic acid levels in cultured human peripheral monocytes. J Clin Endocrinol Metab 1989;69:1200–6
   PubMed Web of Science ®Google Scholar
• Kuklina E, Shirshev S. Reproductive hormones in the control of Th1/Th2 cytokine balance. Biol Bull 2005;32:221–8
   Web of Science ®Google Scholar
• Kim OY, Chae JS, Paik JK, et al. Effects of aging and menopause on serum interleukin-6 levels and peripheral blood mononuclear cell cytokine production in healthy nonobese women. Age 2012;34:415–25
   PubMed Web of Science ®Google Scholar
• Engelmann F, Messaoudi I. The impact of menopause on immune senescence. Open Longev Sci 2012;6:101–11
   Google Scholar
• Nouri M, Ghaffari M, Salmasi A, et al. Effects of IL-6 on steroidogenesis of human granulosa cells in vitro. J Reprod Infertil 2001;2:40–9
   Google Scholar
• Kim MG, Shim JY, Pak JH, et al. Progesterone modulates the expression of interleukin‐6 in cultured term human uterine cervical fibroblasts. Am J Reprod Immunol 2012;67:369–75
   PubMed Web of Science ®Google Scholar
• Girasole G, Jilka R, Passeri G, et al. 17 beta-estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: a potential mechanism for the antiosteoporotic effect of estrogens. J Clin Invest 1992;89:883–91
   PubMed Web of Science ®Google Scholar
• Deb S, Tessier C, Prigent-Tessier A, et al. The expression of interleukin-6 (IL-6), IL-6 receptor, and gp130-kilodalton glycoprotein in the rat decidua and a decidual cell line: regulation by 17β-estradiol and prolactin 1. Endocrinology 1999;140:4442–50
   PubMed Web of Science ®Google Scholar
• Keck C, Herchenbach D, Pfisterer J, Breckwoldt M. Effects of 17beta-estradiol and progesterone on interleukin-6 production and proliferation of human umbilical vein endothelial cells. Exp Clin Endocrinol Diabetes 1997;106:334–9
   Web of Science ®Google Scholar
• Mascitelli L, Goldstein MR. Menopause, estrogen, statins, and the immune system. Maturitas 2011;68:197
   PubMed Web of Science ®Google Scholar
• Vrachnis N, Zygouris D, Iliodromiti Z, Daniilidis A, Valsamakis G, Kalantaridou S. Probing the impact of sex steroids and menopause-related sex steroid deprivation on modulation of immune senescence. Maturitas 2014;78:174–8
   PubMed Web of Science ®Google Scholar
• Ono S, Mochizuki H. [Cytokine production in surgical stress]. Nihon Geka Gakkai zasshi 2000;101:582–7
   PubMedGoogle Scholar
• Bermudez EA, Rifai N, Buring J, Manson JE, Ridker PM. Interrelationships among circulating interleukin-6, C-reactive protein, and traditional cardiovascular risk factors in women. Arterioscler Thromb Vasc Biol 2002;22:1668–73
   PubMed Web of Science ®Google Scholar